Epstein-Barr virus: the molecular virology and the associated diseases

Fujita Med J. 2023 May;9(2):65-72. doi: 10.20407/fmj.2022-018. Epub 2022 Oct 28.

Abstract

Ever since its discovery as the first human oncogenic virus, Epstein-Barr virus (EBV) has been the focus of many researchers and is one of the best-studied pathogens. EBV is a major causative agent of Burkitt lymphoma, Hodgkin lymphoma, post-transplantation lymphoproliferative disorder, NK/T cell lymphoma, chronic active EBV disease, nasopharyngeal carcinoma, gastric carcinoma, and infectious mononucleosis. Although a truly comprehensive understanding of the virus and the associated disorders remains elusive, major breakthroughs in molecular cloning and omics analyses are shedding new light on this important virus. For example, EBV is now implicated in autoimmune diseases and neurodegenerative disorders. This review provides an overview of the molecular biology of EBV, the research history, the associated disorders, and the epidemiology.

Keywords: Autoimmune diseases; Carcinoma; EBV; Infectious mononucleosis; Lymphoma.